Skip to content
10-Q

Quarterly Report

PRESSURE BIOSCIENCES, INC.

0001493152-23-029724

← back to feed
Filed
Aug 21, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 17.76M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $24.98K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $3.87K
Current Liabilities Q2 2023 · Jun 30, 2023 $26.54M
Current Liabilities Q2 2023 · Dec 31, 2022 $34.4M
Total Liabilities Q2 2023 · Jun 30, 2023 $26.79M
Total Liabilities Q2 2023 · Dec 31, 2022 $34.7M
Current Assets Q2 2023 · Jun 30, 2023 $1.05M
Current Assets Q2 2023 · Dec 31, 2022 $1.24M
Total Assets Q2 2023 · Jun 30, 2023 $1.68M
Total Assets Q2 2023 · Dec 31, 2022 $2.01M
Shares Diluted Q2 2023 · Jun 30, 2022 10.46M sh
Shares Diluted Q2 2023 · Jun 30, 2022 10.03M sh
Capex Q2 2023 · Jun 30, 2022 $4.89K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$2M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$27.21M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$24.75M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$22.21M
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.32
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.80
Eps Basic Q2 2023 · Jun 30, 2022 −$0.32
Eps Basic Q2 2023 · Jun 30, 2022 −$0.80
Sga Expense Q2 2023 · Jun 30, 2022 $795.47K
Sga Expense Q2 2023 · Jun 30, 2022 $1.7M
Rd Expense Q2 2023 · Jun 30, 2022 $172.73K
Rd Expense Q2 2023 · Jun 30, 2022 $454.32K
Net Income Q2 2023 · Jun 30, 2022 −$2.92M
Net Income Q2 2023 · Jun 30, 2022 −$7.16M
Net Income Q2 2023 · Mar 31, 2022 −$4.24M
Operating Income Q2 2023 · Jun 30, 2022 −$901.63K
Operating Income Q2 2023 · Jun 30, 2022 −$1.99M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $302.14K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $616.5K
Revenue Q2 2023 · Jun 30, 2022 $498.14K
Revenue Q2 2023 · Jun 30, 2022 $978.14K